Reckitt Benckiser Group (LON:RB) Given a GBX 7,700 Price Target by Barclays Analysts

Reckitt Benckiser Group (LON:RB) has been given a GBX 7,700 ($100.61) target price by equities research analysts at Barclays in a research note issued to investors on Friday, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock. Barclays‘s price objective indicates a potential upside of 24.15% from the stock’s previous close.

A number of other analysts also recently commented on the company. Shore Capital restated an “under review” rating on shares of Reckitt Benckiser Group in a report on Tuesday, July 30th. Bryan, Garnier & Co restated a “neutral” rating and set a GBX 6,870 ($89.77) price objective (up from GBX 6,800 ($88.85)) on shares of Reckitt Benckiser Group in a report on Tuesday, July 30th. Deutsche Bank dropped their price objective on Reckitt Benckiser Group from GBX 7,750 ($101.27) to GBX 7,500 ($98.00) and set a “buy” rating for the company in a report on Tuesday. Royal Bank of Canada restated an “underperform” rating and set a GBX 5,900 ($77.09) price objective on shares of Reckitt Benckiser Group in a report on Monday, August 5th. Finally, Liberum Capital restated a “buy” rating on shares of Reckitt Benckiser Group in a report on Tuesday, July 30th. Four analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of GBX 7,033.53 ($91.91).

Shares of RB stock traded up GBX 105 ($1.37) on Friday, reaching GBX 6,202 ($81.04). 434,767 shares of the stock were exchanged, compared to its average volume of 1,720,000. The stock has a market cap of $43.98 billion and a P/E ratio of 31.13. The company has a quick ratio of 0.43, a current ratio of 0.59 and a debt-to-equity ratio of 85.08. The firm has a 50 day moving average of GBX 6,269.66 and a two-hundred day moving average of GBX 6,287.03. Reckitt Benckiser Group has a 1-year low of GBX 5,559 ($72.64) and a 1-year high of GBX 7,174 ($93.74).

In other news, insider Adrian Nevil Hennah sold 81,063 shares of the firm’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of GBX 6,399 ($83.61), for a total transaction of £5,187,221.37 ($6,778,023.48).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: What is Green Investing?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.